CytoDyn Inc. (CYDY) stock
CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
$0.25+0.02 (+9.53%)
Close on Oct 19, 2026Market cap $345.56MP/E –Yield –
CytoDyn enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
CytoDyn's enterprise value was $347.23M on Oct 19, 2026, against $287.26M a year earlier. Over the last 5 years it ranged from $108.90M to $798.06M, with a median of $269.72M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $347.23M | +1.4% |
| 2025 | Dec 31, 2025 | $342.56M | +214.6% |
| 2024 | Dec 31, 2024 | $108.90M | -40.9% |
| 2023 | Dec 29, 2023 | $184.16M | +1.1% |
| 2022 | Dec 30, 2022 | $182.14M | -71.1% |
| 2021 | Dec 31, 2021 | $630.71M | -79.3% |
| 2020 | Dec 31, 2020 | $3.05B | +700.1% |
| 2019 | Dec 31, 2019 | $381.63M | +263.1% |
| 2018 | Dec 31, 2018 | $105.10M | +26.5% |
| 2017 | Dec 29, 2017 | $83.07M | +6.2% |
| 2016 | Dec 30, 2016 | $78.19M | +69.3% |
| 2015 | Dec 31, 2015 | $46.17M | -25.3% |
| 2014 | Dec 31, 2014 | $61.82M | +76.7% |
| 2013 | Dec 31, 2013 | $34.98M | -13.8% |
| 2012 | Dec 31, 2012 | $40.60M | -38.6% |
| 2011 | Dec 30, 2011 | $66.16M | – |
See a number that looks wrong?